BACKGROUND: Human gammadelta (γδ) T cells play an important role in protective immunity in HIV-1 and simian immunodeficiency virus infection; their role in HIV-2 infection is unknown. OBJECTIVE: To determine the role of γδ T cells in control of plasma viral load and CD4 T-cell count in HIV-1 and HIV-2 infections in West Africa. METHODS: Thirty HIV-1 and 25 HIV-2 treatment-naive chronically infected individuals, and 20 HIV-seronegative individuals from Senegal were studied using multiparametric flow cytometry to investigate the frequencies and phenotypes of peripheral γδ T cells. γδ T-cell parameters and correlates of HIV disease progression were assessed. RESULTS: : We observed an expansion of Vδ1 T-cell populations in both HIV-1 and HIV-2 infection. However, unlike HIV-1 infection, no significant contraction of the frequency of total Vδ2 T cells was observed in HIV-2 infection. Significantly lower frequencies of CD4Vδ2 T cells were observed in HIV-2-infected individuals. Furthermore, frequencies of CD28CD45RO and CD27CD28CD45RO Vδ2 T cell were low in HIV-1-infected individuals. Vδ2 T-cell activation levels were elevated in both HIV-1-infected and HIV-2-infected individuals. The frequency of HLA-DRCD38-activated Vδ1 and Vδ2 T cells was associated with a decline in CD4 T-cell counts and increased viral load in both HIV-1 and HIV-2 infection. CONCLUSIONS: Although maintaining the normal frequency of total Vδ2 T cells, HIV-2 infection reduces the frequency of CD4Vδ2 T cells and alters the frequencies of subsets of Vδ1 T cells. Both HIV-1 and HIV-2 infection induce γδ T-cell activation, and this activation is associated with the disease progression.
BACKGROUND:Human gammadelta (γδ) T cells play an important role in protective immunity in HIV-1 and simian immunodeficiency virus infection; their role in HIV-2 infection is unknown. OBJECTIVE: To determine the role of γδ T cells in control of plasma viral load and CD4 T-cell count in HIV-1 and HIV-2 infections in West Africa. METHODS: Thirty HIV-1 and 25 HIV-2 treatment-naive chronically infected individuals, and 20 HIV-seronegative individuals from Senegal were studied using multiparametric flow cytometry to investigate the frequencies and phenotypes of peripheral γδ T cells. γδ T-cell parameters and correlates of HIV disease progression were assessed. RESULTS: : We observed an expansion of Vδ1 T-cell populations in both HIV-1 and HIV-2 infection. However, unlike HIV-1 infection, no significant contraction of the frequency of total Vδ2 T cells was observed in HIV-2 infection. Significantly lower frequencies of CD4Vδ2 T cells were observed in HIV-2-infected individuals. Furthermore, frequencies of CD28CD45RO and CD27CD28CD45RO Vδ2 T cell were low in HIV-1-infected individuals. Vδ2 T-cell activation levels were elevated in both HIV-1-infected and HIV-2-infected individuals. The frequency of HLA-DRCD38-activated Vδ1 and Vδ2 T cells was associated with a decline in CD4 T-cell counts and increased viral load in both HIV-1 and HIV-2 infection. CONCLUSIONS: Although maintaining the normal frequency of total Vδ2 T cells, HIV-2 infection reduces the frequency of CD4Vδ2 T cells and alters the frequencies of subsets of Vδ1 T cells. Both HIV-1 and HIV-2 infection induce γδ T-cell activation, and this activation is associated with the disease progression.
Authors: Kevin K Ariën; Awet Abraha; Miguel E Quiñones-Mateu; Luc Kestens; Guido Vanham; Eric J Arts Journal: J Virol Date: 2005-07 Impact factor: 5.103
Authors: L Hviid; J A Kurtzhals; D Dodoo; O Rodrigues; A Rønn; J O Commey; F K Nkrumah; T G Theander Journal: Infect Immun Date: 1996-10 Impact factor: 3.441
Authors: A D Sarr; Y Lu; J L Sankalé; G Eisen; S Popper; S Mboup; P J Kanki; H Cao Journal: AIDS Res Hum Retroviruses Date: 2001-09-01 Impact factor: 2.205
Authors: N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath Journal: J Virol Date: 2004-12 Impact factor: 5.103
Authors: Levelle D Harris; Nichole R Klatt; Carol Vinton; Judith A Briant; Brian Tabb; Kristin Ladell; Jeffrey Lifson; Jacob D Estes; David A Price; Vanessa M Hirsch; Jason M Brenchley Journal: Blood Date: 2010-07-26 Impact factor: 22.113
Authors: R Marlink; P Kanki; I Thior; K Travers; G Eisen; T Siby; I Traore; C C Hsieh; M C Dia; E H Gueye Journal: Science Date: 1994-09-09 Impact factor: 47.728
Authors: Natasa Strbo; Maria L Alcaide; Laura Romero; Hector Bolivar; Deborah Jones; Eckhard R Podack; Margaret A Fischl Journal: Am J Reprod Immunol Date: 2015-12-15 Impact factor: 3.886
Authors: Vida L Hodara; Laura M Parodi; Deborah Chavez; Lisa M Smith; Robert Lanford; Luis D Giavedoni Journal: J Med Primatol Date: 2014-03-24 Impact factor: 0.667